Interactions among osteoblastic cells, Staphylococcus aureus, and chitosan-immobilized titanium implants in a postoperative coculture system: An in vitro study

Journal of Biomedical Materials Research - Part A

Volumn 104, Issue 3, 2016, Pages 586-594

  Ghimire, Niranjan ^a   Foss, Berit L ^a   Sun, Yuyu ^b   Deng, Ying ^a  

^a University of South Dakota   (United States)

^b University of Massachusetts Lowell   (United States)

Author keywords

antifouling; bacteria related infection (BRI); osteogenic; postoperative; sensitivity

Indexed keywords

BACTERIA; CELLS; CHITOSAN; CYTOLOGY; METAL IMPLANTS; STAPHYLOCOCCUS AUREUS;

ANTIFOULING; ANTIFOULING PROPERTY; BACTERIAL ATTACHMENT; ORTHOPEDIC IMPLANT; OSTEOBLASTIC CELLS; OSTEOGENIC; POSTOPERATIVE; SENSITIVITY;

TITANIUM;

CEFAZOLIN; CHITOSAN; GENTAMICIN; TITANIUM;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIA PROLIFERATION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM ADHERENCE; BONE DEVELOPMENT; BONE REGENERATION; CELL INTERACTION; COCULTURE; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVICE INFECTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FOULING PREVENTION; IMMOBILIZATION; IN VITRO STUDY; INFECTION RATE; NONHUMAN; ORTHOPEDIC IMPLANT; OSTEOBLAST; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; SAOS 2 CELL LINE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURFACE PROPERTY; BIOLOGICAL MODEL; CELL ADHESION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; HUMAN; MICROBIOLOGY; PATHOLOGY; PROCEDURES; SURGICAL INFECTION; TUMOR CELL LINE; ULTRASTRUCTURE;

BACTERIAL ADHESION; CEFAZOLIN; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; COCULTURE TECHNIQUES; GENTAMICINS; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES; SURGICAL WOUND INFECTION; TITANIUM;

EID: 84956591246     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35597     Document Type: Article

References (50)

1. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ., The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: Adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23: 183-189.
2. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J., Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23: 984-991.
3. Mahan J, Seligson D, Henry SL, Hynes P, Dobbins J., Factors in pin tract infections. Orthopedics 1991; 14: 305-308.
4. American Academy of Orthopaedic Surgeons. Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty. Volume 2015: American Academy of Orthopaedic Surgeons; 2004.
5. Knobben BA, van Horn JR, van der Mei HC, Busscher HJ., Evaluation of measures to decrease intra-operative bacterial contamination in orthopaedic implant surgery. J Hosp Infect 2006; 62: 174-180.
6. Berbari EF, Osmon DR, Lahr B, Eckel-Passow JE, Tsaras G, Hanssen AD, Mabry T, Steckelberg J, Thompson R., The Mayo prosthetic joint infection risk score: Implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol 2012; 33: 774-781.
7. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, Dudeck MA, Pollock DA, Horan TC., National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37: 783-805.
8. Greene LR., Guide to the elimination of orthopedic surgery surgical site infections: An executive summary of the Association for Professionals in Infection Control and Epidemiology elimination guide. Am J Infect Control 2012; 40: 384-386.
9. Peersman G, Laskin R, Davis J, Peterson M., Infection in total knee replacement: A retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001; 392: 15-23.
10. Blomgren G., Hematogenous infection of total joint replacement. An experimental study in the rabbit. Acta Orthop Scand Suppl 1981; 187: 1-64.
11. Barth E, Myrvik QM, Wagner W., Gristina AG,. In vitro and in vivo comparative colonization of Staphylococcus aureus and Staphylococcus epidermidis on orthopaedic implant materials. Biomaterials 1989; 10: 325-328.
12. Dexter SJ, Pearson RG, Davies MC, Camara M, Shakesheff KM., A comparison of the adhesion of mammalian cells and Staphylococcus epidermidis on fibronectin-modified polymer surfaces. J Biomed Mater Res 2001; 56: 222-227.
13. Trampuz A, Widmer AF., Infections associated with orthopedic implants. Curr Opin Infect Dis 2006; 19: 349-356.
14. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O., Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35: 322-332.
15. Stewart PS., Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002; 292: 107-113.
16. Dworkin J, Shah IM., Exit from dormancy in microbial organisms. Nat Rev Microbiol 2010; 8: 890-896.
17. Ghimire N, Luo J, Tang R, Sun Y, Deng Y., Novel anti-infective activities of chitosan immobilized titanium surface with enhanced osteogenic properties. Colloids Surf B Biointerfaces 2014; 122: 126-133.
18. Greene AH, Bumgardner JD, Yang Y, Moseley J, Haggard WO., Chitosan-coated stainless steel screws for fixation in contaminated fractures. Clin Orthop Relat Res 2008; 466: 1699-1704.
19. Bumgardner JD, Chesnutt BM, Yuan Y, Yang Y, Appleford M, Oh S, McLaughlin R, Elder SH, Ong JL., The integration of chitosan-coated titanium in bone: An in vivo study in rabbits. Implant Dent 2007; 16: 66-79.
20. Renoud P, Toury B, Benayoun S, Attik G, Grosgogeat B., Functionalization of titanium with chitosan via silanation: Evaluation of biological and mechanical performances. PLoS One 2012; 7: e39367.
21. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG., Animal models for implant biomaterial research in bone: A review. Eur Cells Mater 2007; 13: 1-10.
22. Gristina AG, Naylor P, Myrvik Q., Infections from biomaterials and implants: A race for the surface. Med Prog Technol 1988; 14: 205-224.
23. Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ., The incidence of deep prosthetic infections in a specialist orthopaedic hospital: A 15-year prospective survey. J Bone Joint Surg Br 2006; 88: 943-948.
24. Charnley J, Eftekhar N., Postoperative infection in total prosthetic replacement arthroplasty of the hip-joint. With special reference to the bacterial content of the air of the operating room. Br J Surg 1969; 56: 641-649.
25. Tsukayama DT, Estrada R, Gustilo RB., Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78: 512-523.
26. Adachi K, Tsurumoto T, Yonekura A, Nishimura S, Kajiyama S, Hirakata Y, Shindo H., New quantitative image analysis of staphylococcal biofilms on the surfaces of nontranslucent metallic biomaterials. J Orthop Sci 2007; 12: 178-184.
27. Bowler PG, Welsby S, Hogarth A, Towers V., Topical antimicrobial protection of postoperative surgical sites at risk of infection with Propionibacterium acnes: An in-vitro study. J Hosp Infect 2013; 83: 232-237.
28. Subbiahdoss G, Kuijer R, Busscher HJ, van der Mei HC., Mammalian cell growth versus biofilm formation on biomaterial surfaces in an in vitro post-operative contamination model. Microbiology 2010; 156: 3073-3078.
29. Amorena B, Gracia E, Monzon M, Leiva J, Oteiza C, Perez M, Alabart JL, Hernandez-Yago J., Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 1999; 44: 43-55.
30. Burgers R, Gerlach T, Hahnel S, Schwarz F, Handel G, Gosau M., In vivo and in vitro biofilm formation on two different titanium implant surfaces. Clin Oral Implants Res 2010; 21: 156-164.
31. Amoroso PF, Adams RJ, Waters MG, Williams DW., Titanium surface modification and its effect on the adherence of Porphyromonas gingivalis: An in vitro study. Clin Oral Implants Res 2006; 17: 633-637.
32. Klokkevold PR, Nishimura RD, Adachi M, Caputo A., Osseointegration enhanced by chemical etching of the titanium surface. A torque removal study in the rabbit. Clin Oral Implants Res 1997; 8: 442-447.
33. Wong M, Eulenberger J, Schenk R, Hunziker E., Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res 1995; 29: 1567-1575.
34. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA, and others. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 2007; 28: 1711-1720.
35. Carlson RP, Taffs R, Davison WM, Stewart PS., Anti-biofilm properties of chitosan-coated surfaces. J Biomater Sci Polym Ed 2008; 19: 1035-1046.
36. Tang H, Zhang P, Kieft TL, Ryan SJ, Baker SM, Wiesmann WP, Rogelj S., Antibacterial action of a novel functionalized chitosan-arginine against Gram-negative bacteria. Acta Biomater 2010; 6: 2562-2571.
37. Naylor PT, Myrvik QN, Gristina A., Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci. Clin Orthop Relat Res 1990; 126-133.
38. Webb LXGE, deAraujo B., Surface adherent Staphylococci and enhancement of antibiotic resistance. Tran Ortho Res Soc 1993; 18: 455.
39. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA., Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007; 28: 4880-4888.
40. Yao C, Webster TJ., Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method. J Biomed Mater Res Part B Appl Biomater 2009; 91B: 587-595.
41. Trampuz A, Zimmerli W., Antimicrobial agents in orthopaedic surgery-Prophylaxis and treatment. Drugs 2006; 66: 1089-1105.
42. Craig WA, Ebert SC., Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 1992; 36: 2577-2583.
43. Hanberger H, Nilsson LE, Maller R, Nilsson M., Pharmacodynamics of beta-lactam antibiotics on Gram-negative bacteria: Initial killing, morphology and postantibiotic effect. Scand J Infect Dis Suppl 1990; 74: 118-123.
44. Zeller V, Durand F, Kitzis MD, Lhotellier L, Ziza JM, Mamoudy P, Desplaces N., Continuous cefazolin infusion to treat bone and joint infections: Clinical efficacy, feasibility, safety, and serum and bone concentrations. Antimicrob Agents Chemother 2009; 53: 883-887.
45. Kasiakou SK, Sermaides GJ, Michalopoulos A, Soteriades ES, Falagas ME., Continuous versus intermittent intravenous administration of antibiotics: A meta-analysis of randomised controlled trials. Lancet Infect Dis 2005; 5: 581-589.
46. Kirby WM, Regamey C., Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis 1973; 128: S341-S346.
47. Fields MT, Herndon BL, Bamberger DM., beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses. Antimicrob Agents Chemother 1993; 37: 203-206.
48. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ., A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130: 797-810.
49. Turnidge J., Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin North Am 2003; 17: 503 +.
50. Sidhu PK, Kaur G, Kumbhar G, Balaje RM, Gupta MP., Optimization of dosage regimen of gentamicin against Pasteurella multocida in bovines: Old drug. New approach. J Vet Sci Technol 2014; 5: 199-206.